Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 28, 2017; 23(48): 8582-8590
Published online Dec 28, 2017. doi: 10.3748/wjg.v23.i48.8582
Table 1 Univariate analysis of correlation between lymph node metastasis and clinicopathological parameters of T1-stage colorectal cancer patients
Clinicopathological characteristicnLymph node metastasis
χ2P value
YesNo
Gender1.9550.162
Male17211161
Female14916133
Age (yr)0.4360.509
≥ 6017413161
< 6014714133
Smoking0.7660.382
No27922257
Yes42537
Preoperative CEA (ng/mL)5.9940.014
< 528420264
≥ 537730
Preoperative CA199 (ng/mL)5.0150.025
< 91739164
≥ 914818130
Preoperative CA724 (ng/mL)12.2750.000
< 21635158
≥ 215822136
Granulocyte absolute value0.7710.380
< 2.232428
≥ 2.228923266
D-dimer2.2270.136
< 0.2115817141
≥ 0.2116310153
Preoperative hemoglobin1.5040.220
< 13215416138
≥ 13216711156
Vascular invasion18.4210.000
No31323290
Yes844
Tumor location1.1840.277
Rectum17017153
Colon15110141
Tumor size (cm)1.5260.217
< 319019171
≥ 31318123
Differentiation degree7.7230.005
High/moderate30723284
Low14410
Tumor general type0.2190.640
Ulcer23819219
Non-ulcer83875
Tumor tissue type2.2930.130
Non-adenocarcinoma927
Adenocarcinoma31225287
Table 2 Multivariate analysis of correlation between lymph node metastasis and clinicopathological parameters of T1-stage colorectal cancer patients
Clinicopathological characteristicHRP value95%CI
Lower boundUpper bound
Gender, Male vs Female1.6360.2010.6985.518
Age (yr), < 60 vs ≥ 600.0630.8010.3572.218
Smoking No vs Yes0.8800.3480.5296.077
Preoperative CEA (ng/mL) < 5 vs ≥ 51.1880.2760.6035.904
Preoperative CA199 (ng/mL) < 9 vs ≥ 92.7650.0960.8695.541
Preoperative CA724 (ng/mL) < 2 vs ≥ 25.4610.0191.23210.783
Granulocyte absolute value, < 2.2 vs ≥ 2.20.0040.9510.2853.797
D-dimer < 0.21 vs ≥ 0.211.3980.2370.6515.652
Preoperative hemoglobin < 132 vs ≥ 1320.4370.5080.2491.992
Tumor size (cm), < 3 vs ≥ 32.0900.1480.1851.290
Vascular invasion, No vs Yes8.4610.0042.35881.596
Tumor location, Rectum vs Colon0.2640.6070.4853.444
Differentiation degree, High/moderate vs Low4.2040.0401.05711.956
Tumor general type, Non-ulcer vs Ulcer0.6860.4070.5564.239
Tissue type, Non-adenocarcinoma vs Adenocarcinoma0.8970.3440.0432.989
Table 3 Univariate analysis of correlation between clinicopathological parameters and 5-year overall survival
Clinicopathological characteristicnOS rateχ2P value
Gender1.2250.268
Male17290.90%
Female14990.10%
Age (yr)6.1030.013
≥ 6017486.50%
< 6014795.50%
Smoking0.4290.513
No27991.00%
Yes4287.50%
Preoperative CEA (ng/mL)13.5940.000
< 528492.70%
≥ 53778.40%
Preoperative CA199 (ng/mL)7.2290.007
< 917394.70%
≥ 914885.70%
Preoperative CA724 (ng/mL)0.0120.912
< 216387.40%
≥ 215893.20%
Granulocyte absolute value1.6130.204
< 2.23285.00%
≥ 2.228991.00%
D-dimer0.0010.979
< 0.2115888.80%
≥ 0.2116391.90%
Preoperative hemoglobin0.9070.341
< 13215489.10%
≥ 13216791.70%
Vascular invasion12.9550.000
No31391.60%
Yes840.00%
Tumor location1.1210.290
Rectum17089.80%
Colon15191.90%
Tumor size (cm)0.2100.647
< 319090.00%
≥ 313191.20%
Differentiation degree6.8250.009
High/moderate30791.30%
Low1478.60%
Tumor general type3.1490.207
Protruded22891.80%
Infiltration10100.00%
Ulcer8386.20%
Tumor tissue type1.8280.176
Non-adenocarcinoma975.00%
Adenocarcinoma31291.30%
Lymph node metastasis24.1800.000
No29493.20%
Yes2765.20%
Table 4 COX regression analysis of correlation between clinicopathological parameters and 5-year overall survival
RRP value95%CI
Lower boundUpper bound
Gender, Male vs Female1.7840.1820.6956.816
Age (yr), < 60 vs ≥ 603.8050.0510.9959.034
Smoking, No vs Yes0.5900.4420.4137.565
Preoperative CEA, (ng/mL), < 5 vs ≥ 51.1210.2900.5806.206
Preoperative CA199, (ng/mL), < 9 ≥ 96.4520.0111.41114.481
Preoperative CA724, (ng/mL), < 2 ≥ 20.9350.3330.2011.725
Granulocyte absolute value, < 2.2 vs ≥ 2.20.0400.8410.1718.761
D-dimer, < 0.21 ≥ 0.212.3730.1230.7778.217
Preoperative hemoglobin, < 132 vs ≥ 1320.5770.4480.1982.042
Tumor size (cm), < 3 vs ≥ 30.5810.4460.26121.193
Vascular invasion, No vs Yes0.3430.5580.4684.076
Tumor location, Rectum vs Colon0.2100.6470.3102.068
Differentiation degree, High/moderate vs Low1.0310.3100.43513.792
Tumor general type, Ulcer vs Non-ulcer2.3380.1260.8115.471
Tumor tissue type, Non-adenocarcinoma vs Adenocarcinoma0.7830.3760.0682.755
Lymph node metastasis, No vs Yes5.3280.0211.26417.592